NOVELTY - Lipase comprising a polypeptide or peptide comprising an amino acid sequence of SEQ ID Nos: 1-19, or an amino acid sequence that has at least 45%, preferably at least 99%, amino acid sequence identity with it, is new, where the sequences not defined here may be found at ftp://ftp.wipo.int/pub/published-pct-sequences/publication.    USE - The lipase is useful: as a catalyst in the preparation of a polymer, preferably a high molecular weight polymer, such as bioplastic, biocompatible or biodegradable polymer in the form of a film, a fiber or a nanoparticle, amorphous or crystalline and a copolymer optionally comprising a diacid, a diol or a hydroxyl acid; for enzyme-catalytic conversion or enantioselective conversion of substrates; for preparing optically active compounds; in the preparation of biofuels, preferably biodiesel; and for oil biodegradation, waste treatment and leather degreasing. The peptide or polypeptide, the nucleic acid sequence and/or antibody are/is useful for treating a patient with a disease (all claimed). The lipase is useful: e.g. in a detergent composition for dish washing and in the removal of fat from meat including fish meat; and for preparing sausages and determining the changes in the long-chain fatty acids liberated during the ripening of the sausages, refining rice flavor modifying soybean milk for improving the aroma and accelerating the fermentation of apple wine, the preparation of enzyme modified cheeses and the enhancement of flavor of dairy products such as cheese, coffee whiteners, milk, butter and yoghurt. No biological data given.    DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for:    (1) a nucleic acid molecule comprising a sequence of nucleotides, which encode a polypeptide or peptide or fragment or variant, or are complementary to the nucleic acid sequence of the nucleic acid molecule or hybridizable to the nucleic acid sequence of the nucleic acid molecule under stringent conditions;    (2) a host cell containing the nucleic acid molecule;    (3) a vector comprising a nucleic acid sequence, which encodes the lipase, or a nucleic acid sequence of the nucleic acid molecule;    (4) the preparation of the lipase;    (5) an antibody that binds specifically with one or more lipases;    (6) a process-I for enzyme-catalytic conversion or enantioselective conversion of substrates, comprising reacting one or more substrates in the presence of the lipase;    (7) a lipase formulation comprising the lipase;    (8) a process-II for preparing optically active compounds comprising reacting stereoisomeric mixtures or racemates of a substrate in an enzyme catalyzed manner enantioselectively in the presence of a lipase, and resolving the mixture;    (9) a diagnostic kit comprising the lipase, or an antibody binding to the lipase;    (10) a method of diagnosis comprising contacting a sample with the lipase or the antibody; and    (11) a composition comprising a combination of two or more peptides or polypeptides, combination of two or more nucleic acid sequences and/or a combination of two or more antibodies.